FDA approves Medtronic’s innovative spinal cord stimulator for chronic pain treatment

FDA approves Medtronic’s innovative spinal cord stimulator for chronic pain treatment

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced a significant advancement in the treatment of chronic pain with the U.S. Food and Drug Administration (FDA) approval of its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). This device represents a major leap forward in pain management technology, featuring the first-of-its-kind closed-loop system […]